Fundraising Fox

Drew King

Investor

Partner at Cure Ventures Β· Board director at Crosslink Therapeutics

Boston, Massachusetts

Writes $100K – $5M checks Β· typically $1.5M

About

Partner and Chief Financial Officer overseeing finance and operations at the firm and portfolio companies. Previously VP of Finance at Bain Capital and a finance manager at Absolute Return Capital, with seven years at Ernst & Young.

Board director at Crosslink Therapeutics

Intro paths

β†’

In turn, Drew can intro founders to Crosslink Therapeutics's investors below.

Crosslink Therapeutics's investors Β· 1

Experience

  1. Cure VenturesPartner and Chief Financial Officercurrent2021 β€” present
  2. Bain CapitalVice President2012 β€” 2021
  3. Ernst & YoungManager2005 β€” 2012

Skills & more

  • Certified Public Accountant β€” Massachusetts Board of Public Accountancy
  • Series 3 (inactive) β€” National Futures Association

From Drew's professional profile.

Colleagues at Cure Ventures

Network5

Investors connected to Drew in public investor directories β€” a warm-intro map.

Frequently asked questions

Who is Drew King?
Partner and Chief Financial Officer overseeing finance and operations at the firm and portfolio companies. Previously VP of Finance at Bain Capital and a finance manager at Absolute Return Capital, with seven years at Ernst & Young.
Where does Drew King work?
Drew King is Partner at Cure Ventures and Board director at Crosslink Therapeutics.
What check size does Drew King write?
Drew King typically writes checks of $100K – $5M.
Where did Drew King go to school?
Drew King studied at University of Virginia (MS, Accounting); Bentley University (BS, Corporate Finance & Accounting); Regent's University London.

Same school

Shared employers